BUZZ-SpaceX seeks 40 billions USD in financing to purchase Nvidia chips, stock price drops in response
路透社2026/10/07 08:51October 7 - SpaceX (SPCX.O) shares fell 1.8% in premarket trading to $168.9. According to the Financial Times, citing people familiar with the matter, the company plans to raise $40 billions to acquire Nvidia (NVDA.O) AI chips. The Financial Times reports that the proposed financing, led by Apollo Global Management (APO.N), includes around $10 billions in bank loans and $30 billions in investment-grade bonds to pay for the chip orders. This move by Elon Musk's company underscores the enormous capital required amid the AI boom, as tech companies race to expand their computing infrastructure. SpaceX, Apollo Global Management, and Nvidia have yet to respond to Reuters' requests for comment. Out of 41 brokerages, 32 have a "Buy" or higher rating on the stock, 6 rate it "Hold," and 3 as "Sell" or lower; the median target price is $217, according to data compiled by London Stock Exchange Group (LSEG). As of the previous trading session close, SPCX shares have risen 27.3% from their IPO price of $135.
October 7 - ** SpaceX (SPCX.O) shares fell 1.8% premarket to $168.9
** According to the Financial Times, citing sources familiar with the matter, the company (link) plans to raise $40 billion to purchase artificial intelligence chips from NVIDIA NVDA.O
** The Financial Times reports that the proposed funding, led by Apollo Global Management APO.N, includes about $10 billion in bank loans and $30 billion in investment-grade bonds, which will be used to pay for the chip order—Financial Times
** This move by the company led by Elon Musk highlights the massive capital required by the artificial intelligence boom, as tech firms race to expand their computing infrastructure
** SpaceX, Apollo Global Management, and NVIDIA have not yet responded to Reuters' requests for comment
** Out of 41 brokerages, 32 rate the stock as “buy” or higher, 6 as “hold”, and 3 as “sell” or lower; the median target price is $217—data compiled by London Stock Exchange Group (LSEG)
** As of the previous trading day's close, SPCX stock was up 27.3% from its IPO price of $135
(To facilitate non-native English speakers, Reuters has automated its reports into several other languages. Due to potential errors in automated translation or lack of appropriate context, Reuters does not guarantee the accuracy of the automated translation, which is provided solely for the convenience of readers. Reuters accepts no liability for any harm or loss arising from the use of this automated translation function.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Gold Price Forecast: XAU/USD retraces gains and nears two-month lows at $4,104
BUZZ-Caribou shares plunge as company explores sale and cancels cancer project
October 7 - ** Caribou Biosciences (CRBU.O) shares fell 35.9% in pre-market trading to $0.72 ** Caribou Biosciences announced late Tuesday that it is exploring strategic options, including a potential sale, merger, or other transactions, to maximize shareholder value ** Caribou said it plans to halt development of its allogeneic CAR-T cell therapy programs, including vispa-cel for non-Hodgkin lymphoma and CB-011 for multiple myeloma ** Caribou also stated it will lay off employees and cut costs, with most layoffs expected to be completed by Q4 2026 ** As of June 30, the company held $113.8 millions in cash, cash equivalents, and marketable securities ** As of the previous trading day's close, the company's share price had dropped about 28% year-to-date (Note: For the convenience of non-English speakers, Reuters automatically translates its reports into several other languages. Since automated translations may be inaccurate or lack necessary context, Reuters does not guarantee the accuracy of automated translation texts and provides them only for reader convenience. Reuters assumes no responsibility for any damages or losses resulting from the use of automated translation features.)
Australian Dollar: Neutral outlook inside tight range against US Dollar – UOB
Crypto prices
More
